Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Rezolute, Inc. - Common Stock (NV)
(NQ:
RZLT
)
4.700
-0.020 (-0.42%)
Streaming Delayed Price
Updated: 1:02 PM EDT, Aug 3, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Rezolute, Inc. - Common Stock (NV)
< Previous
1
2
3
4
Next >
Rezolute to Participate in the BTIG Virtual Biotechnology Conference
July 21, 2026
From
Rezolute, Inc.
Via
GlobeNewswire
Rezolute Highlights Results Presented from Natural History Outcomes Studies and its Ersodetug Clinical Program in Hyperinsulinism at Annual Meeting of the Endocrine Society
June 17, 2026
From
Rezolute, Inc.
Via
GlobeNewswire
Rezolute Announces Four Presentations at the Upcoming Annual Meeting of the Endocrine Society
June 04, 2026
From
Rezolute, Inc.
Via
GlobeNewswire
Rezolute Announces Positive Interim Data for its Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism
June 02, 2026
From
Rezolute, Inc.
Via
GlobeNewswire
Rezolute Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update
May 12, 2026
From
Rezolute, Inc.
Via
GlobeNewswire
Rezolute to Participate in Upcoming Investor Conferences
May 11, 2026
From
Rezolute, Inc.
Via
GlobeNewswire
Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting
May 01, 2026
From
Rezolute, Inc.
Via
GlobeNewswire
Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society (PES) Annual Meeting
April 21, 2026
From
Rezolute, Inc.
Via
GlobeNewswire
Rezolute Provides Update on its Congenital Hyperinsulinism Program Following FDA Meeting
March 24, 2026
FDA encourages the Company to submit comprehensive data from sunRIZE and the ongoing open-label extension to inform next steps for the program
From
Rezolute, Inc.
Via
GlobeNewswire
RZLT INVESTOR ALERT: Faruqi & Faruqi, LLP Launches Investigation into Rezolute
March 06, 2026
From
Faruqi & Faruqi, LLP
Via
Business Wire
Rezolute to Participate in the Citizens Life Sciences Conference
March 04, 2026
From
Rezolute, Inc.
Via
GlobeNewswire
RZLT SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
March 03, 2026
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
February 26, 2026
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
RZLT INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
February 19, 2026
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
RZLT SECURITIES ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
February 15, 2026
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Rezolute Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update
February 12, 2026
From
Rezolute, Inc.
Via
GlobeNewswire
Rezolute to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
February 04, 2026
From
Rezolute, Inc.
Via
GlobeNewswire
SHAREHOLDER INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
February 03, 2026
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
RZLT INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
January 23, 2026
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rezolute, Inc. - RZLT
January 20, 2026
From
Pomerantz LLP
Via
GlobeNewswire
RZLT INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
January 14, 2026
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rezolute, Inc. - RZLT
January 13, 2026
From
Pomerantz LLP
Via
GlobeNewswire
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
January 08, 2026
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Rezolute Provides Insights from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism and Shares Findings from its Expanded Access Program in Tumor Hyperinsulinism
January 07, 2026
From
Rezolute, Inc.
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rezolute, Inc. - RZLT
January 06, 2026
From
Pomerantz LLP
Via
GlobeNewswire
INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RZLT
January 03, 2026
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rezolute, Inc. - RZLT
December 30, 2025
From
Pomerantz LLP
Via
GlobeNewswire
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
December 24, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
December 21, 2025
From
Faruqi & Faruqi, LLP
Via
Business Wire
REZOLUTE INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RZLT
December 19, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
